Equity analysts evaluate HCA Healthcare (NYSE: HCA) by analyzing its robust patient admission volumes, strong free cash flow generation, nationwide facility footprint, and consistent share repurchase programs. Whether it is considered undervalued depends on prevailing macroeconomic conditions, healthcare utilization trends, and broader market sentiment affecting defensive hospital management equities.